Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; the references it cites are not checked yet; 13 of the 134 sources its claims cite were checked for support.

Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications

Open access
Caldara, Marina, Marmiroli, Nelson·2021·Pharmaceuticals

Abstract

The spreading of antibiotic resistance is responsible annually for over 700,000 deaths worldwide, and the prevision is that this number will increase exponentially. The identification of new antimicrobial treatments is a challenge that requires scientists all over the world to collaborate. Developing new drugs is an extremely long and costly process, but it could be paralleled by drug repositioning. The latter aims at identifying new clinical targets of an “old” drug that has already been tested, approved, and even marketed. This approach is very intriguing as it could reduce costs and speed up approval timelines, since data from preclinical studies and on pharmacokinetics, pharmacodynamics, and toxicity are already available. Antidepressants and antipsychotics have been described to inhibit planktonic and sessile growth of different yeasts and bacteria. The main findings in the field are discussed in this critical review, along with the description of the possible microbial targets of these molecules. Considering their antimicrobial activity, the manuscript highlights important implications that the administration of antidepressants and antipsychotics may have on the gut microbiome.

Overview

CoChat Summary

TL;DR

This critical review summarizes evidence that antidepressants and antipsychotics have antimicrobial activity against bacteria, fungi, and some viruses, with *Candida albicans* as a common target, and discusses drug repositioning implications. It highlights possible mechanisms and argues that effects on the gut microbiome and microbial targets require further study before these drugs can be considered true antimicrobials.

Key findings

  • Antimicrobial resistance causes over 700,000 deaths annually worldwide; new drug development can take up to 17 years, and discovery of new antibacterial agents has dropped by more than 50%, motivating drug repositioning.
  • Antidepressants and antipsychotics inhibit planktonic and sessile growth of different yeasts and bacteria; sertraline is the most studied, active in some cases at 9 µM, tested on more than 20 microbes, and able to inhibit *C. albicans* virulence factors and biofilm while synergizing with fluconazole.
  • Working concentrations are within the range of known antimicrobials (for *C. albicans*, fluconazole MIC90 is around 3 µM), and combinations with azoles or amphotericin B show fractional inhibitory index well below 0.5.
  • Proposed mechanisms include inhibition of efflux pumps, disturbance of mitochondria, and disruption of membranes or lipid rafts; some TCAs and thioridazine resensitize MRSA to β-lactam, and phenelzine, desipramine, venlafaxine, bupropion, aripiprazole, and (S)citalopram inhibited gut commensals such as *Bifidobacterium animalis* and *Bacteroides fragilis*.

Methods

  • Critical/perspective review based on bibliographic searches from May to August 2021 in PubMed, Elsevier’s Scopus, Web of Science Clarivate Analytics, and Google Scholar, using keyword combinations such as sertraline-antimicrobial, sertraline-repurposing, sertraline-fungi, and SSRIs-bacteria.
  • The paper synthesizes in vitro and some in vivo studies in Table 1, listing drug class, microbial target, effective concentration, physiological effects, and references, then discusses proposed mechanisms and implications for gut ecology.

Limitations

  • The paper states that examined reports do not include specific details on mechanism of action and molecular targets, that less is known about effects on bacteria, and that more studies are needed to identify microbial targets, gut microbiome effects after short or prolonged administration, active antimicrobial concentrations, topical use, and combination effects.
  • The paper notes that almost all Table 1 papers report in vitro testing, with only some in vivo testing, and that clinical data on gut microbiota and serotonergic signaling remain very limited; studies in depressed patients often occurred during treatment, so more pre- and post-treatment microbiome data are needed.
  • Evident from the text: as a narrative critical review, it does not report a systematic search protocol, risk-of-bias assessment, or meta-analysis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ph14090915

Cites

Statistics

Nothing to recompute.

Figures

Figure 1 Proposed mechanisms of action. Few are the mechanisms of action suggested for antidepressants and antipsychotics. They involve inhibition of efflux pumps (A), disturbance of mitochondria (B) (a list of possible functions that can be affected in the organelle are reported), and disruption of the integrity of membranes or lipid rafts (C). Moreover, with chemogenomics and the use of barcoded mutants (D), pathways and molecular targets of different psychoactive drugs were discovered in the model organisms S. cerevisiae and C. albicans. Future studies will need to confirm these findings. Part of the graph was made using https://smart.servier.com/ (accessed on 1 July 2021).
Figure 1 Proposed mechanisms of action. Few are the mechanisms of action suggested for antidepressants and antipsychotics. They involve inhibition of efflux pumps (A), disturbance of mitochondria (B) (a list of possible functions that can be affected in the organelle are reported), and disruption of the integrity of membranes or lipid rafts (C). Moreover, with chemogenomics and the use of barcoded mutants (D), pathways and molecular targets of different psychoactive drugs were discovered in the model organisms S. cerevisiae and C. albicans. Future studies will need to confirm these findings. Part of the graph was made using https://smart.servier.com/ (accessed on 1 July 2021).CC BY · PubMed Central
Figure 2 Chemical structure of some SSRIs, MAOIs, TCAs, and neuroleptics which highlights similarities and differences between the different chemicals.
Figure 2 Chemical structure of some SSRIs, MAOIs, TCAs, and neuroleptics which highlights similarities and differences between the different chemicals.CC BY · PubMed Central

Verification

Claims the paper makes

10 Valid · 3 Not valid · 81 Not checked · 20 Own results and interpretations

67 more claims · 2 with their cited sources checked

Create a free account to see all 114 claims and to verify the 121 references still open.

See all claims — free account
  • It may state two separate claims as one. 31
  • Probably not a substantial claim. 16

Create a free account to see these claims.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 120 · Cited by 54

Research works printed but not linked: 2

  1. Szarmach, 2017, Benzodiazepines in combination with antipsychotic drugs for schizophrenia: GABA-ergic targeted therapy, Psychiatr. Danub., 29, S345
  2. Lang, 2012, Recent progress of acridine derivatives with antitumor activity, Prog. Chem., 24, 1497

Metadata

Authors
Caldara, M., & Marmiroli, N.
Affiliations
University of Parma (IT)
Corresponding author
Caldara, Marina
Venue
Pharmaceuticals
Publisher
MDPI AG
Published
2021-09-10
Volume
14
Issue
9
Pages
915
ISSN
1424-8247 (ISSN-L)
OpenAlex
W3200385998
Cited by
54
References
120
Citations by year
2026: 12 · 2025: 13 · 2024: 12 · 2023: 10 · 2022: 7
FWCI
0.57
Type
journal article
Language
en
Open access
Locations
  • Pharmaceuticals (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
Keywords
antidepressants, antipsychotic drugs, antimicrobial activity, drug repurposing, antibiotic resistance, gut microbiota, yeast growth inhibition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications. https://app.cochat.ai/papers/10.3390/ph14090915
The paper
Caldara, M., & Marmiroli, N. (2021). Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications. Pharmaceuticals. https://doi.org/10.3390/ph14090915

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.